Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study

Chloé Melchior (1, 2, 3, 4) , Moutaz Aziz (5) , Typhaine Aubry (4) , Guillaume Gourcerol (6, 2, 3, 1) , Muriel Quillard (7, 8) , Alberto Zalar (4) , Moïse Coëffier (2, 3, 9, 1) , Pierre Dechelotte (9, 2, 3, 1) , Anne-Marie Leroi (6, 2, 3, 1) , Philippe Ducrotté (4, 2, 3, 1)

1 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
2 ADEN - Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau
3 IRIB - Institute for Research and Innovation in Biomedicine
4 Service d'Hépato-Gastroentérologie [CHU Rouen]
5 Service d'Anatomie et Cytologie Pathologique [CHU Rouen]
6 Service de physiologie digestive, urinaire, respiratoire et de l'exercice [CHU Rouen]
7 Laboratoire de biochimie générale [Rouen]
8 UNIROUEN - Université de Rouen Normandie
9 Service de nutrition [CHU Rouen]

Domains: Life Sciences [q-bio]; Human health and pathology; Hépatology and Gastroenterology

Chloé Melchior, Moutaz Aziz, Typhaine Aubry, Guillaume Gourcerol, Muriel Quillard, et al.. Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study. United European Gastroenterology Journal, 2017, 5 (2), pp.261-269. ⟨10.1177/2050640616650062⟩. ⟨hal-02308044⟩